TWIST1 and breast carcinoma: In the context of basal-like breast cancer (BLBC), the abnormal presence of Twist1 induces EMT and properties akin to cancer stem cells, simultaneously suppressing ERα expression to enhance the resistance of breast cancer cells to chemotherapy drugs [31].